X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline
Management der X-chromosomalen Hypophosphatämie bei Kindern: klinische Leitlinie einer internationalen Arbeitsgruppe
The Journal of Clinical Endocrinology & Metabolism · 17.06.2025 · 110 (7) · 2055-2070
DOI: 10.1210/clinem/dgaf093 ↗Auf einen Blick
Eine internationale Arbeitsgruppe hat neue Empfehlungen zur Diagnose, Behandlung und Überwachung von X-chromosomaler Hypophosphatämie (XLH) bei Kindern erstellt. Grundlage waren zwei systematische Reviews und weitere Evidenzsynthesen.
Fragestellung
Wie sollen Diagnose, Bewertung, Behandlung und Überwachung von XLH bei Kindern erfolgen?
Methode
Klinische Praxisleitlinie; 50 internationale Expert:innen, 18 Telekonferenzen 2023-2024; 2 systematische Reviews, narrative Reviews und Expertenbefragung; GRADE.
Ergebnisse
Es wird ein Vorgehen zur Diagnosestellung vorgestellt. GRADE-Empfehlungen wurden zur Behandlung von XLH bei Kindern entwickelt; Überwachungsempfehlungen basierten auf einer Expertenbefragung.
Schlussfolgerung der Autor:innen
Die Leitlinie aktualisiert die Evidenz zu Diagnose und Management von XLH und bietet umfassende Orientierung für multidisziplinäre Behandler:innen.
Kernaussagen
- Neue Leitlinie zu Diagnose, Behandlung und Monitoring von XLH bei Kindern
- 2 systematische Reviews und weitere Evidenzsynthesen
- Überwachungsempfehlungen mit sehr geringer Evidenzsicherheit
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Leitlinie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 17.02.2025. Verfasst von Dalal S Ali und 43 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, McMaster University, Hamilton, ON, Canada L8S 4L8. Hauptthemen laut MEDLINE: Familial Hypophosphatemic Rickets. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Calcium Disorders Clinic, McMaster University.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Context
An International Working Group (IWG) developed new guidelines on the diagnosis, evaluation, management, and monitoring of X-linked hypophosphatemia (XLH) in children. Over the past 5 years, important advances have occurred in our understanding of the presentation, complications, and treatment of XLH.
Methods
A group of 50 international experts in XLH from Canada, the United States, Europe, Asia, and South America, along with methodology experts and a patient partner, held 18 teleconference meetings in 2023-2024. These meetings addressed key issues regarding diagnosing, evaluating, managing, and monitoring XLH in children. Two systematic reviews were conducted to examine the impact of burosumab compared to conventional therapy (phosphate salts and active vitamin D) or no therapy, and to assess the impact of conventional therapy vs no therapy on patient-important outcomes. The certainty of evidence was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. Additionally, narrative reviews were completed on XLH diagnosis and the role of genetic testing, and an expert clinical practice survey informed the monitoring recommendations. Outcomes An approach to establishing the diagnosis of XLH is presented. GRADEd recommendations were developed on treatment strategies for XLH in children. Monitoring recommendations, GRADEd as weak with very low certainty, were based on clinical practice survey of the IWG experts. The guidelines also addressed dental complications and proposed potential strategies to mitigate them.
Conclusion
These clinical practice guidelines provide an update of the current evidence on the diagnosis and management of XLH and provide a comprehensive guidance for multidisciplinary healthcare professionals involved in the care of children with XLH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, McMaster University, Hamilton, ON, Canada L8S 4L8.
- Departments of Pediatrics (Endocrinology), and Orthopedics and Rehabilitation, Yale University School of Medicine, New Haven, CT 06520, USA.
- Department of Medicine and Pediatrics, Endocrinology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Children's Hospital of Eastern Ontario, Department of Pediatrics, University of Ottawa, Ottawa, ON K1H 8L1, Canada.
- Department of Internal Medicine, Division of Endocrinology, Center for Bone Quality, Leiden University Medical Center, 2300 ZA Leiden, The Netherlands.
- Department of Oral Medicine, Faculty of Dentistry, UMR 1333, Université Paris Cité, 75006 Paris, France.
ORCID-Profile: Dalal S Ali, Thomas O Carpenter, Erik A Imel, Leanne M Ward, Natasha M Appelman-Dijkstra, Catherine Chaussain, Suzanne M Jan de Beur, Pablo Florenzano, Hajar Abu Alrob, R Todd Alexander, Farah Alsarraf, Signe Sparre Beck-Nielsen, Martin Biosse-Duplan, Rachel K Crowley, Karel Dandurand, Guido Filler, Lisa Friedlander, Seiji Fukumoto, Claudia Gagnon, Paul Goodyer, Corinna Grasemann, Chelsey Grimbly, Salma Hussein, Muhammad K Javaid, Sarah Khan, Aneal Khan, Anna Lehman, Willem F Lems, E Michael Lewiecki, Ciara McDonnell, Reza D Mirza, Emmett Morgante, Anthony A Portale, Yumie Rhee, Eric T Rush, Heide Siggelkow, Sotirios Tetradis, Laura Tosi, Gordon Guyatt, Maria Luisa Brandi, Aliya A Khan
Förderung
- Calcium Disorders Clinic
- McMaster University
Zitieren
APA
Ali, D. S., Carpenter, T. O., Imel, E. A., Ward, L. M., Appelman-Dijkstra, N. M., Chaussain, C., Jan de Beur, S. M., Florenzano, P., Abu Alrob, H., Aldabagh, R., Alexander, R. T., Alsarraf, F., Beck-Nielsen, S. S., Biosse-Duplan, M., Crowley, R. K., Dandurand, K., Filler, G., Friedlander, L., Fukumoto, S., …, & Khan, A. A. (2025). X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 110(7), 2055-2070. https://doi.org/10.1210/clinem/dgaf093
Vancouver
Ali DS, Carpenter TO, Imel EA, Ward LM, Appelman-Dijkstra NM, Chaussain C, et al. X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2025;110(7):2055-2070. doi:10.1210/clinem/dgaf093
BibTeX
@article{Ali2025,
author = {Ali, Dalal S and Carpenter, Thomas O and Imel, Erik A and Ward, Leanne M and Appelman-Dijkstra, Natasha M and Chaussain, Catherine and Jan de Beur, Suzanne M and Florenzano, Pablo and Abu Alrob, Hajar and Aldabagh, Rana and Alexander, R Todd and Alsarraf, Farah and Beck-Nielsen, Signe Sparre and Biosse-Duplan, Martin and Crowley, Rachel K and Dandurand, Karel and Filler, Guido and Friedlander, Lisa and Fukumoto, Seiji and Gagnon, Claudia and Goodyer, Paul and Grasemann, Corinna and Grimbly, Chelsey and Hussein, Salma and Javaid, Muhammad K and Khan, Sarah and Khan, Aneal and Lehman, Anna and Lems, Willem F and Lewiecki, E Michael and McDonnell, Ciara and Mirza, Reza D and Morgante, Emmett and Morrison, Archibald and Portale, Anthony A and Rao, Christina and Rhee, Yumie and Rush, Eric T and Siggelkow, Heide and Tetradis, Sotirios and Tosi, Laura and Guyatt, Gordon and Brandi, Maria Luisa and Khan, Aliya A},
title = {X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
volume = {110},
number = {7},
pages = {2055--2070},
doi = {10.1210/clinem/dgaf093}
}
EUVIMED